Long-term results of collagen crosslinking with riboflavin and UVA in keratoconus

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 10, 2008, Pages 1616-1617

  Iovieno, Alfonso ^a   Oechsler, Rafael A ^a   Yoo, Sonia H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; RIBOFLAVIN;

CELL COUNT; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; CORNEA THICKNESS; CROSS LINKING; CYTOTOXICITY; FOLLOW UP; HUMAN; IN VITRO STUDY; IRRADIATION; KERATOCONUS; LETTER; MAJOR CLINICAL STUDY; MICROSCOPY; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

COLLAGEN; CORNEAL STROMA; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; KERATOCONUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 52049107096     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.05.055     Document Type: Letter

References (4)

1. Raiskup-Wolf F., Hoyer A., Spoerl E., and Pillunat L.E. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 34 (2008) 796-801
2. Wollensak G., Spoerl E., and Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135 (2003) 620-627
3. Wollensak G., Spörl E., Reber F., Pillunat L., and Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 35 (2003) 324-328
4. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17 (2006) 356-360